Skip to main content
ATOS logo

ATOS · Atossa Therapeutics, Inc. · Share Buybacks

Track ATOS — free
$1.65 -0.10 (-5.71%) Q2 2023 earnings call transcript
Market Cap
$15.92M
Shares
9.98M
Volume · Nov 20 48.93K Avg daily vol (3M) 67.59K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$10,000,000
as of 2023-06-27 · not restated in filings since 2025-03-25

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2026-02-20 $50,000,000 — —
2024-11-19 $100,000,000 — —

Repurchase History

Fiscal Year Ended Cash Spent
2024-12-31 $0
2023-12-31 $1,475,000
2022-12-31 $0
Key facts CIK 1488039 CUSIP 04962H704 13F (30d) 61 filings 35 filers Visit website Investor relations